Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Appointed director
|
|
Surface Oncology, Inc. (SURF)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Adams Chandra (Deputy GC) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 3,901 shares
@ $0.94, valued at
$3.7k
|
|
| 08/11/2023 |
4
| FEES JESSICA (CFO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 9,434 shares
@ $0.94, valued at
$8.9k
|
|
| 08/11/2023 |
4
| ONEILL ALISON (Chief Medical Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 7,042 shares
@ $0.94, valued at
$6.6k
|
|
| 08/11/2023 |
4
| ROSS ROBERT W. (CEO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 16,713 shares
@ $0.94, valued at
$15.7k
|
|
| 03/03/2023 |
4
| RATH HENRY C. (Chief Business Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.69, valued at
$103.5k
|
|
| 03/03/2023 |
4
| ROSS ROBERT W. (CEO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.69, valued at
$276k
|
|
| 03/03/2023 |
4
| Adams Chandra (Deputy GC) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.69, valued at
$34.5k
|
|
| 03/03/2023 |
4
| ONEILL ALISON (Chief Medical Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.69, valued at
$103.5k
|
|
| 03/03/2023 |
4
| FEES JESSICA (CFO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.69, valued at
$103.5k
|
|
| 03/03/2023 |
4
| Palombella Vito J. (Chief Scientific Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.69, valued at
$103.5k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| RATH HENRY C. (Chief Business Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 5,676 shares
@ $1.72, valued at
$9.8k
|
|
| 08/05/2022 |
4
| ONEILL ALISON (Chief Medical Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 4,463 shares
@ $1.72, valued at
$7.7k
|
|
| 08/05/2022 |
4
| ROSS ROBERT W. (CEO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 10,594 shares
@ $1.72, valued at
$18.2k
|
|
| 08/05/2022 |
4
| FEES JESSICA (CFO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 5,980 shares
@ $1.72, valued at
$10.3k
|
|
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Brunn Carsten (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 48,000 options to buy
@ $1.74, valued at
$83.5k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.01, valued at
$48.2k
|
|
| 06/10/2022 |
4
| Goater Jeff (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.01, valued at
$48.2k
|
|
| 04/01/2022 |
4
| Boni Theresa (General Counsel & Secretary) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 120,000 options to buy
@ $2.87, valued at
$344.4k
|
|
| 03/03/2022 |
4
| ROSS ROBERT W. (CEO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 56,000 shares
@ $0
Granted 359,000 options to buy
@ $3.64, valued at
$1.3M
|
|
| 03/03/2022 |
4
| ONEILL ALISON (Chief Medical Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 38,000 shares
@ $0
Granted 108,000 options to buy
@ $3.64, valued at
$393.1k
|
|
| 03/03/2022 |
4
| RATH HENRY C. (Chief Business Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 38,000 shares
@ $0
Granted 108,000 options to buy
@ $3.64, valued at
$393.1k
|
|
| 03/03/2022 |
4
| FEES JESSICA (CFO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 38,000 shares
@ $0
Granted 108,000 options to buy
@ $3.64, valued at
$393.1k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2022 |
4
| Goater Jeff (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 127,778 shares
@ $6.1, valued at
$779.4k
|
|
| 01/14/2022 |
4
| FEES JESSICA (CFO) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 19,854 shares
@ $6.1, valued at
$121.1k
|
|
| 01/14/2022 |
4
| Palombella Vito J. (Chief Scientific Officer) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 26,325 shares
@ $6.1, valued at
$160.6k
|
|
|
|
|